Fox Chase Cancer Center
SABCS Takeaways on HR+ eBC: Neoadjuvant Weekly Nab-Paclitaxel vs. Dose Dense Paclitaxel, ET Alone in Intermediate / High-Risk Luminal Disease, NCT in Postmenopausal Women Resistant to ET
By
Fox Chase Cancer Center
FEATURING
Jennifer Matro
By
Fox Chase Cancer Center
FEATURING
Jennifer Matro
Comments 0
Login to view comments.
Click here to Login
